v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2024   48,755,451    
Beginning Balance at Dec. 31, 2024 $ 28,424   $ 443,734 $ (415,310)
Exercise of common stock options (in shares)   164,770    
Exercise of common stock options 280   280  
Stock-based compensation expense 1,406   1,406  
Net Income (Loss) (23,735)     (23,735)
Ending Balance (in shares) at Mar. 31, 2025   48,920,221    
Ending Balance at Mar. 31, 2025 6,375   445,420 (439,045)
Beginning Balance (in shares) at Dec. 31, 2025   153,372,044    
Beginning Balance at Dec. 31, 2025 9,458 $ 1 565,721 (556,264)
Exercise of pre-funded warrants   4,843,179    
Stock-based compensation expense 2,531   2,531  
Issuance of common stock under employee stock purchase plan (in shares)   433,740    
Issuance of common stock under employee stock purchase plan 170   170  
Net Income (Loss) 9,218     9,218
Ending Balance (in shares) at Mar. 31, 2026   158,648,963    
Ending Balance at Mar. 31, 2026 $ 21,377 $ 1 $ 568,422 $ (547,046)